Home/Hedge Fund Intelligence/TG Therapeutics, Inc.
Nasdaq: TGTXStockForm 13F30 Jun 2026

Hedge funds that hold TG Therapeutics, Inc. Nasdaq: TGTX

CUSIP 88322Q108 · who reports it, how much, and how much it matters to them

27 of the 720 hedge fund managers we track reported shares of TG Therapeutics, Inc. (Nasdaq: TGTX) on Form 13F for 30 June 2026. Between them they reported USD 555m. The largest position belongs to D. E. Shaw & Co., at USD 187m. The manager with the most riding on it is M28 Capital Management, where it is 10.3% of the reported book.

Managers reporting it27of 720 we track
Value they reportUSD 555mshares only, 30 Jun 2026
Funds they run484with a file on PPLI.com
Largest positionUSD 187mD. E. Shaw & Co.
Typical weight0.0%median share of a manager's book
Heaviest weight10.3%M28 Capital Management

Compiled from SEC Form 13F filings · Hedge Fund Intelligence, PPLI.com · updated

Form 13F is filed by the manager and covers all of its accounts, so a position here belongs to the firm, not to any one fund. Not investment advice.

13F
What this page is

A list of every manager in our coverage that reported this share at the end of the quarter, taken from the filings themselves. Short positions and options are not in it.

Who holds it

27 managers, USD 555m between them

Taken from each manager's Form 13F for 30 June 2026. A manager appears here if it reported the shares themselves; positions held only through options are left out.

Every manager that reports TG Therapeutics, Inc., largest position first

The bar and the percentage show how much of the manager's reported 13F book the position makes up. Each name opens that manager's largest fund on PPLI.com, where the rest of its book is listed.

#ManagerValue reportedShare of its book
1D. E. Shaw & Co.15 funds on PPLI.comUSD 187m0.1%
2Two Sigma Investments35 funds on PPLI.comUSD 136m0.1%
3Renaissance Technologies13 funds on PPLI.comUSD 37m0.1%
4Citadel Advisors32 funds on PPLI.comUSD 30m0.0%
5Bridgewater Associates45 funds on PPLI.comUSD 24m0.1%
6683 Capital Management2 funds on PPLI.comUSD 21m1.1%
7Weiss Asset Management5 funds on PPLI.comUSD 21m0.2%
8Millennium Management6 funds on PPLI.comUSD 15m0.0%
9POINT72 Asset Management17 funds on PPLI.comUSD 15m0.0%
10Walleye Capital8 funds on PPLI.comUSD 10m0.0%
11Squarepoint Ops7 funds on PPLI.comUSD 9.2m0.0%
12Exome Asset Management2 funds on PPLI.comUSD 9.1m5.6%
13Exoduspoint Capital Management7 funds on PPLI.comUSD 9m0.1%
14Aquatic Capital Management3 funds on PPLI.comUSD 5.5m0.2%
15Tudor Investment Corporation10 funds on PPLI.comUSD 5.2m0.0%
16M28 Capital Management1 fund on PPLI.comUSD 4.9m10.3%
17Edgestream Partners5 funds on PPLI.comUSD 3.8m0.1%
18Capital Fund Management S.A.12 funds on PPLI.comUSD 3.8m0.0%
19Schonfeld Strategic Advisors30 funds on PPLI.comUSD 3.6m0.0%
20Verition Fund Management3 funds on PPLI.comUSD 2m0.0%
21Brevan Howard Capital Management39 funds on PPLI.comUSD 1.4m0.0%
22Capstone Investment Advisors25 funds on PPLI.comUSD 693,0000.0%
23Engineers Gate Manager1 fund on PPLI.comUSD 589,0000.0%
24Fora Capital1 fund on PPLI.comUSD 457,0000.0%
25Marshall Wace LLP84 funds on PPLI.comUSD 316,0000.0%
26CIBC Asset Management69 funds on PPLI.comUSD 263,0000.0%
27Fulcrum Asset Management LLP7 funds on PPLI.comUSD 10,9210.0%
Next: where it matters most
Where it matters most

For M28 Capital Management it is 10.3% of the book

A large manager can hold a great deal of a share and barely notice it. This table turns the question round and ranks managers by how much of their own book the position takes up.

#ManagerValue reportedShare of its book
1M28 Capital ManagementUSD 4.9m10.3%
2Exome Asset ManagementUSD 9.1m5.6%
3683 Capital ManagementUSD 21m1.1%
4Weiss Asset ManagementUSD 21m0.2%
5Aquatic Capital ManagementUSD 5.5m0.2%
6Edgestream PartnersUSD 3.8m0.1%
7Two Sigma InvestmentsUSD 136m0.1%
8Bridgewater AssociatesUSD 24m0.1%
9D. E. Shaw & Co.USD 187m0.1%
10Exoduspoint Capital ManagementUSD 9m0.1%
Next: how to read this
How to read this

What a 13F list can and cannot tell you

  • It is the manager's filing, not a fund's. Form 13F covers every account a firm runs. We cannot say which of its funds holds the shares.
  • It is a snapshot. The list shows the last day of the quarter. A manager may have bought or sold since, and trading inside the quarter leaves no trace.
  • It shows one side. Short positions, swaps and shares listed outside the United States are not reported, so a manager on this list may be hedged or net short.
  • It covers the managers we track. Our coverage is 720 managers of hedge and private funds. Banks, index funds and other institutions that file Form 13F are not counted here.
Next: questions
Questions

Questions about who holds TG Therapeutics, Inc.

What is the ticker symbol of TG Therapeutics, Inc.?

TG Therapeutics, Inc. trades under the symbol TGTX on the Nasdaq. Its CUSIP, the code used on Form 13F, is 88322Q108.

Which hedge funds own TG Therapeutics, Inc. (Nasdaq: TGTX)?

27 of the 720 hedge fund managers PPLI.com tracks reported TG Therapeutics, Inc. shares on Form 13F for 30 June 2026. The largest reported positions were held by D. E. Shaw & Co. (USD 187m), Two Sigma Investments (USD 136m), Renaissance Technologies (USD 37m), Citadel Advisors (USD 30m) and Bridgewater Associates (USD 24m).

How many hedge funds hold TG Therapeutics, Inc.?

27 managers in our coverage reported it, and between them they run 484 funds with a file on PPLI.com. The count is of managers, because Form 13F is filed by the firm and not by each fund.

Which manager has the most riding on TG Therapeutics, Inc.?

M28 Capital Management, where the position was 10.3% of the reported 13F book at 30 June 2026.

Does this show who is short TG Therapeutics, Inc.?

No. Form 13F reports long positions in U.S.-listed shares and options. Short positions are not disclosed in it.

Important information

Positions are taken by PPLI.com from Form 13F filings with the U.S. Securities and Exchange Commission for the quarter shown. They are reported by each manager, cover all of its accounts and may have changed since. PPLI.com has no relationship with TG Therapeutics, Inc. or with the managers listed.

Nothing here is investment, tax or legal advice, a recommendation, or an offer or solicitation to buy or sell any security. To report an error, write to the editor.

Private consultation →
Step 1 of 2

Tell us about yourself

Read our Privacy Policy before submitting. Share only the information needed to describe your question; do not include medical records or account credentials.

✦Research assistant
✦PPLI.comResearch assistant
Explore PPLI questions and suitability factors
Ask a general question about PPLI, or explore the factors that affect suitability. Treat the answer as a starting point and check the linked sources.
Use the research with your own tax, legal and insurance advisers.
Preparing an answer
AI assistant. Educational information only. It does not determine eligibility or provide personal tax, legal, investment or insurance advice.